On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...